H1N1 백신 시장 : 투여 경로, 브랜드 유형, 유통 채널별 - 세계 예측(2025-2030년)

The H1N1 Vaccines Market was valued at USD 9.93 billion in 2023, expected to reach USD 13.45 billion in 2024, and is projected to grow at a CAGR of 35.51%, to USD 83.39 billion by 2030.

The H1N1 vaccine market scope and definition revolve around the development, production, and distribution of vaccines aimed at combating the H1N1 influenza virus, commonly known as swine flu. The necessity for these vaccines stems from the global health risk presented by flu outbreaks, which can lead to widespread illness and mortality. Applications primarily include immunization efforts targeting high-risk populations such as healthcare workers, children, the elderly, and those with compromised immune systems. End-use scope spans public health initiatives, hospital and clinical settings, and government stockpiling strategies. Market growth is driven by factors such as increasing awareness of infectious disease prevention, advancements in vaccine technology, and supportive governmental health policies. Recent market dynamics highlight potential opportunities in the expansion within emerging markets, leveraging mRNA technology for rapid vaccine development, and enhancing cold chain logistics to ensure vaccine stability and reach in remote areas. Recommendations to seize these opportunities include investing in advanced research and development (R&D) for next-generation vaccines, forging strategic partnerships for broad distribution networks, and engaging in public-private collaborations to enhance health infrastructure.

However, limitations include regulatory hurdles that can delay vaccine approval, political and logistical challenges in global distribution, and public vaccine hesitancy amplified by misinformation. Addressing these challenges calls for continuous education efforts and transparent communication about vaccine safety and efficacy. The best possible areas of innovation involve developing universal flu vaccines, enhancing vaccine storage and delivery systems, and integrating digital health technologies for better tracking and managing vaccine distribution. Insight into the nature of this market reveals it to be highly competitive and rapidly evolving, driven by the dual imperatives of addressing immediate public health needs and anticipating future outbreaks. Successful engagement requires strategic foresight and agility to navigate the complexities inherent in the vaccine landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving H1N1 Vaccines Market

The H1N1 Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of epidemic H1N1 infection
  • Demand for inactivated influenza vaccine in pregnant women and children
  • Shift towards cell-based manufacturing
• Market Restraints
  • Time consuming manufacturing process and high cost
• Market Opportunities
  • Public-private partnerships for cost effective supply
  • Technological advancements in the vaccines
• Market Challenges
  • Common side effects associated with H1N1 vaccines

Porter's Five Forces: A Strategic Tool for Navigating the H1N1 Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the H1N1 Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the H1N1 Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the H1N1 Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the H1N1 Vaccines Market

A detailed market share analysis in the H1N1 Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the H1N1 Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the H1N1 Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the H1N1 Vaccines Market

A strategic analysis of the H1N1 Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the H1N1 Vaccines Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc., Cipla Limited, Cochin Shipyard Ltd., Glaxo Smith Kline, Hualan Biological Engineering Inc., MedImmune, LLC, Merck KGaA, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Sanofi S.A., and Sinovac Biotech Ltd..

Market Segmentation & Coverage

This research report categorizes the H1N1 Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Route of Administration, market is studied across Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines.
• Based on Type of Brand, market is studied across Agripal, Fiuarix, Influgen, Influvac, Nasovac, and Vaxigrip.
• Based on Distribution Channel, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of epidemic H1N1 infection
    • 5.1.1.2. Demand for inactivated influenza vaccine in pregnant women and children
    • 5.1.1.3. Shift towards cell-based manufacturing
  • 5.1.2. Restraints
    • 5.1.2.1. Time consuming manufacturing process and high cost
  • 5.1.3. Opportunities
    • 5.1.3.1. Public-private partnerships for cost effective supply
    • 5.1.3.2. Technological advancements in the vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. Common side effects associated with H1N1 vaccines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. H1N1 Vaccines Market, by Route of Administration

• 6.1. Introduction
• 6.2. Intradermal Vaccines
• 6.3. Intramuscular Vaccines
• 6.4. Intranasal Vaccines

7. H1N1 Vaccines Market, by Type of Brand

• 7.1. Introduction
• 7.2. Agripal
• 7.3. Fiuarix
• 7.4. Influgen
• 7.5. Influvac
• 7.6. Nasovac
• 7.7. Vaxigrip

8. H1N1 Vaccines Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacy
• 8.3. Online Pharmacy
• 8.4. Retail Pharmacy

9. Americas H1N1 Vaccines Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific H1N1 Vaccines Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa H1N1 Vaccines Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Baxter International Inc.
• 3. Cipla Limited
• 4. Cochin Shipyard Ltd.
• 5. Glaxo Smith Kline
• 6. Hualan Biological Engineering Inc.
• 7. MedImmune, LLC
• 8. Merck KGaA
• 9. Mitsubishi Tanabe Pharma Corporation
• 10. Pfizer Inc.
• 11. Sanofi S.A.
• 12. Sinovac Biotech Ltd.